{"DataElement":{"publicId":"4743613","version":"1","preferredName":"Chemotherapy Most Recent Everolimus Or mTOR Inhibitor Administered Time Duration Unit of Measure Code","preferredDefinition":"The response indicating the units of measure used when administering chemotherapy using everolimus or other mTOR inhibitor.","longName":"EVE_MTOR_INH_UOM_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"4722946","version":"1","preferredName":"Chemotherapy Most Recent Everolimus Or mTOR Inhibitor Administered","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases._Nearest to the present._A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05)_An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Any substance that inhibits mammalian target of rapamycin (mTOR or FK506 binding protein 12-rapamycin associated protein 1 (FRAP1)), a serine/threonine protein kinase that is active in the control of cell growth, cell proliferation, and cell motility. Inhibition of mTOR can inhibit cell proliferation._The act of having given something (e.g., a medication or test).","longName":"2404910v1.0:4722944v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2404910","version":"1","preferredName":"Chemotherapy","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)","longName":"C15632","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-12DD-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-09-13","modifiedBy":"ONEDATA","dateModified":"2005-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4722944","version":"1","preferredName":"Most Recent Everolimus Or mTOR Inhibitor Administered","preferredDefinition":"Nearest to the present.:A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05):An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Any substance that inhibits mammalian target of rapamycin (mTOR or FK506 binding protein 12-rapamycin associated protein 1 (FRAP1)), a serine/threonine protein kinase that is active in the control of cell growth, cell proliferation, and cell motility. Inhibition of mTOR can inhibit cell proliferation.:The act of having given something (e.g., a medication or test).","longName":"4722944v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Most Recent","conceptCode":"C25577","definition":"Nearest to the present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Everolimus","conceptCode":"C48387","definition":"A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05)","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"mTOR Inhibitor","conceptCode":"C2201","definition":"Any substance that inhibits mammalian target of rapamycin (mTOR or FK506 binding protein 12-rapamycin associated protein 1 (FRAP1)), a serine/threonine protein kinase that is active in the control of cell growth, cell proliferation, and cell motility. Inhibition of mTOR can inhibit cell proliferation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8FFE3B-36A1-E261-E050-BB89AD430EB0","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-02-20","modifiedBy":"ONEDATA","dateModified":"2015-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8FFE3B-36B2-E261-E050-BB89AD430EB0","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"9149_Theradex_02.20.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2017056","version":"5","preferredName":"Time Duration Unit of Measure Code","preferredDefinition":"Unit of Measure 2-letter code to represent the length of time for an event._The continuum of experience in which events pass from the future through the present to the past._The period of time during which something continues._A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.","longName":"DUR_UOM_CD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MN","valueDescription":"Minutes","ValueMeaning":{"publicId":"2562322","version":"1","preferredName":"Minutes","longName":"2562322","preferredDefinition":"A unit measure of time equal to 60 seconds.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minute","conceptCode":"C48154","definition":"A unit measure of time equal to 60 seconds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C07F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF52-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"HR","valueDescription":"Hours","ValueMeaning":{"publicId":"2562324","version":"1","preferredName":"Hours","longName":"2562324","preferredDefinition":"In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hour","conceptCode":"C25529","definition":"A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C081-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF5C-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"DY","valueDescription":"Days","ValueMeaning":{"publicId":"2562325","version":"1","preferredName":"Days","longName":"2562325","preferredDefinition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Day","conceptCode":"C25301","definition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C082-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF66-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"WK","valueDescription":"Weeks","ValueMeaning":{"publicId":"2562323","version":"1","preferredName":"Weeks","longName":"2562323","preferredDefinition":"Any period of seven consecutive days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C080-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF70-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"CO","valueDescription":"Course","ValueMeaning":{"publicId":"2569377","version":"1","preferredName":"Course","longName":"2569377","preferredDefinition":"A period of protocol-prescribed activity or intervention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Course","conceptCode":"C25379","definition":"Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC0E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-23","modifiedBy":"COOPERM","dateModified":"2008-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF7A-09E3-E040-BB89AD4363D5","beginDate":"2004-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"MO","valueDescription":"Month","ValueMeaning":{"publicId":"2569689","version":"1","preferredName":"Month","longName":"2569689","preferredDefinition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DD46-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"BMCCURRY","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF84-09E3-E040-BB89AD4363D5","beginDate":"2004-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"SC","valueDescription":"Second","ValueMeaning":{"publicId":"2577221","version":"1","preferredName":"Second","longName":"2577221","preferredDefinition":"The second is the unit of time, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the ground state of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour. Abbreviation Sec. is acceptable in non-scientific usage only.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C42535","definition":"A unit of time, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FAB2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BFC0-09E3-E040-BB89AD4363D5","beginDate":"2009-04-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"YR","valueDescription":"Year","ValueMeaning":{"publicId":"2670939","version":"1","preferredName":"Year","longName":"2670939","preferredDefinition":"The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Year","conceptCode":"C29848","definition":"A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36BD5C9D-C863-5705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB9B4554-3069-0765-E053-4EBD850ADFC5","beginDate":"2022-04-01","endDate":null,"createdBy":"LISU","dateCreated":"2022-04-01","modifiedBy":"ONEDATA","dateModified":"2022-04-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008558","version":"1","preferredName":"Units of Measure","preferredDefinition":"the units of measure for assessment results and dosing.","longName":"UOM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2DECB93-42CA-248A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-28","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2860382","version":"1","preferredName":"Time Duration Unit of Measure Code","preferredDefinition":"the continuum of experience in which events pass from the future through the present to the past.:The period of time during which something continues.:A named quantity in terms of which other quantities are measured or specified used as a standard measurement of same kinds, such as pound or kilogram in measuring weight. (NCI):A system of numbered categories for representation of data.","longName":"C25207:C25330:C25709:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Time","conceptCode":"C25207","definition":"The continuum of experience in which events pass from the future through the present to the past.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Duration","conceptCode":"C25330","definition":"The period of time during which something continues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unit of Measure","conceptCode":"C25709","definition":"A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6735C50D-B59F-1A32-E040-BB89AD434C1D","latestVersionIndicator":"Yes","beginDate":"2009-04-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-04-10","modifiedBy":"ONEDATA","dateModified":"2009-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB9B5BC2-BF3C-09E3-E040-BB89AD4363D5","latestVersionIndicator":"Yes","beginDate":"2013-11-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"LISU","dateModified":"2022-04-01","changeDescription":"Replaces v4.0 of this VD in order to edit the PV SC (v4.0 used SEC, corrected PV is SC in this version 5.0)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Units","type":"Preferred Question Text","description":"Units","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1105A90E-71BA-ED37-E050-BB89AD43028A","latestVersionIndicator":"Yes","beginDate":"2015-03-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-11","modifiedBy":"HARTLEYG","dateModified":"2015-03-11","changeDescription":"9149_Theradex_03.11.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}